Answers are grounded in this paper and cite their sources.
Reports recurrent coronary thrombosis following anticoagulant cessation in a patient with Hodgkin lymphoma, indicating secondary antiphospholipid syndrome as a critical cause of reocclusion.
A 41-year-old gentleman with a recent history of Hodgkin’s lymphoma sustained an acute inferior wall myocardial infarction, managed with percutaneous coronary inter-vention, thromboaspiration and stenting in a totally occluded right coronary artery. He was placed on triple antithrombotic treatment with dual antiplatelet therapy and oral anticoagulation because of a large thrombotic load in the right coronary artery. Three months later and 5 days after discontinuation of prescribed oral anticoagulant, he had a new acute coronary event due to acute reocclusion in the right coronary ar-tery. Thrombus aspiration and repeat angioplasty restored vessel patency. The patient was put back on triple antithrombotic therapy and was investigated for uncommon causes of blood hypercoagulability. Blood assays revealed elevated anti-β2 glycopro-tein I (anti-β2GPI) (IgM) and anticardiolipin antibodies (IgM), consistent with a di-agnosis of secondary antiphospholipid syndrome. I n T R o d u C T I o n Coronary thrombosis as a manifestation of the antiphospholipid syndrome (APS) is rather uncommon. Patients with APS usually present with recurrent episodes of deep
No takes yet. Share an insight, caveat, or question.
Metaxa et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: